Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Alternate Symbol(s):  CRPOF

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > AEZS q1 fins due May 15
View:
Post by lscfa on Apr 29, 2024 12:37pm

AEZS q1 fins due May 15

Will CZO wait until May 30 per TSXV rules or man up and follow Nasdaq rules?
Comment by prophetoffactz on Apr 29, 2024 2:03pm
Bigger question: Who is behind the ~2.75 million shares that has been bid for CZO? Is Bloom Burton going to initiate coverage? What could the target price be? Will H.C. Wainwright also initiate new coverage? H.C. Wainwright had a C$100 million market cap target for AEZS before the merger. What could the target price be for the merged company? Having shown no adverse events to 480mg and given the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities